This inability to differentiate abnormal Tau-PET scans from normal ones is in agreement with previous results34,37 and could be because p-tau217 is known to be an early AD biomarker and may be unable to effectively detect tau aggregate pathology that is visible with tau PET imaging37. Here, MAPT is linked to Alzheimer disease.